Renal toxicity and carcinogenicity of trichloroethylene: Key results, mechanisms, and controversies

Critical Reviews in Toxicology

Volumn 30, Issue 3, 2000, Pages 253-285

  Brüning, Thomas ^a   Bolt, Hermann M ^a  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

GST polymorphisms; Nephrotoxicity; Renal carcinogenicity; Trichloroethylene; VHL gene

Indexed keywords

GLUTATHIONE TRANSFERASE; TRICHLOROETHYLENE;

CHEMICAL CARCINOGENESIS; CHEMICAL STRUCTURE; GENE MUTATION; GENOTOXICITY; HUMAN; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; LEYDIG CELL TUMOR; LIVER TUMOR; LUNG TUMOR; METABOLISM; NEPHROTOXICITY; NONHUMAN; REVIEW; SPECIES DIFFERENCE; TOXICOKINETICS; TUMOR SUPPRESSOR GENE; UROTHELIUM;

ANIMALIA; RODENTIA;

EID: 1642633556     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408440091159202     Document Type: Review

References (130)

1. IARC, Trichloroethylene. In: International Agency for Research on Cancer, Ed. Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. Lyon: IARC, 1995, 75-158. (IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 63).
2. DFG, Trichlorethen. In: Greim, H. and Henschler, H., Eds. Toxikologisch-arbeitsmedizinische Begründungen von MAK-Werten. Weinheim: VCHVerlagsgesellschaft, 1996.
3. Kautiainen, A., Vogel, J. S., and Turteltaub, K. W., Dose-dependent binding of trichloroethylene to hepatic DNA and protein at low doses in mice, Chem. Biol. Interact., 1997; 106: 109-121.
4. Robbiano, L., Mereto, E., Morando, A. M., Pastore, P., and Brambilla, G., Increased frequency of micronucleated kidney cells in rats exposed to halogenated anesthetics, Mutat. Res., 1998; 413: 1-6.
5. Müller, M., Birner, G., Henschler, D., and Dekant, W., Structures of DNA adducts formed from haloketenes and halothioketenes: A study to identify possible adducts formed from trichloro-and perchloroethene through bioactivation by glutathione conjugation, IARC Sci. Publ., 1994; 115: 423-428.
6. Müller, M., Birner, G., and Dekant, W., Reactivity of haloketenes and halothioketenes with nucleobases: chemical characterization of reaction products, Chem. Res. Toxicol., 1998; 11: 454-463.
7. Völkel, W. and Dekant, W., Chlorothioketene, the ultimate reactive intermediate formed by cysteine conjugate beta-lyase-mediated cleavage of the trichloroethylene metabolite S-(1,2-dichlorovinyl)-L-cysteine, forms cytosine adducts in organic solvents, but not in aqueous solution, Chem. Res. Toxicol., 1998; 11: 1082-1088.
8. Goeptar, A. R., Commandeur, J. N. M., van Ommen, B., van Bladeren, P. J., and Vermeulen, N. P. E., Metabolism and kinetics of trichloroethylene in relation to carcinogenicity. Relevance of the mercapturic acid pathway, Chem. Res. Toxicol., 1995; 8: 3-21.
9. Byington, K. H, and Leibman, K. C., Metabolism of trichloroethylene in liver microsomes. II. Identification of the reaction product as chloral hydrate, Mol. Pharmacol., 1965; 1: 247-254.
10. Leibman, K. C., Metabolism of trichloroethylene in liver microsomes. I. Characteristics of the reaction, Mol. Pharmacol., 1965; 1: 239-246.
11. Dekant, W., Metzler, M., and Henschler, D., Identification of S-1,2-dichlorovinyl-N-acetyl-cysteine as a urinary metabolite of trichloroethylene: a possible explanation for its nephrocarcinogenicity in male rats, Biochem. Pharmacol., 1986; 35: 2455-2458.
12. Commandeur, J. N., and Vermeulen, N. P., Identification of N-acetyl(2,2-dichlorovinyl)-and N-acetyl( 1,2-dichlorovinyl)-L-cysteine as two regioisomeric mercapturic acids of trichloroethylene in the rat, Chem. Res. Toxicol., 1990; 3: 212-218.
13. Dekant, W., Koob, M., and Henschler, D., Metabolism of trichloroethylene - in vivo and in vitro evidence for activation by glutathione conjugation, Chem. Biol. Interact., 1990; 73: 89-101.
14. Nakajima, T., Wang, R. S., Elovaara, E., Park, S. S., Gelboin, H. V., and Vainio, H., A comparative study on the contribution of cytochrome P-450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver, Biochem. Pharmacol., 1992; 43: 251-257.
15. Lipscomb, J. C., Garrett, C. M., and Snawder, J. E., Use of kinetic and mechanistic data in species extrapolation of bioactivation: Cytochrome P-450 dependent trichloroethylene metabolism at occupationally relevant concentrations, J. Occup. Health, 1998; 40: 110-117.
16. Miller, R. E. and Guengerich, F. P., Oxidation of trichloroethylene by liver microsomal cytochrome P-450: evidence for chlorine migration in a transition state not involving trichloroethylene oxide, Biochemistry, 1982; 21: 1090-1097.
17. Bolt, H. M., Biologische Arbeitsstoff-Toleranzwerte: BAT-Wert für Trichloräthylen, Arbeitsmed. Sozialmed. Präventivmed., 1981; 16: 116-121.
18. Müller, G., Spassovski, M., and Henschler, D., Trichloroethylene exposure and trichloroethylene metabolites in urine and blood, Arch. Toxicol., 1972; 29: 335-340.
19. Dekant, W., Metabolic conversion of tri-and tetrachloroethylene: formation and deactivation of genotoxic intermediates. In: Chambers, P. L., Gehring, P., and Sakai, F., Eds. New Concepts and Developments in Toxicology. Proceedings of the 4th International Congress in Toxicology, Tokyo. New York: Elsevier, 1986, 211-221.
20. Dekant, W., Urban, G., Görsman, C., and Anders, M. W., Thioketene formation from haloalkenyl 2-nitrophenyl disulfides: models for biological reactive intermediates of cytotoxic S-conjugates, J. Am. Chem. Soc., 1991; 113: 5120-5122.
21. Koob, M. and Dekant, W., Bioactivation of xenobiotics by formation of toxic glutathione conjugates, Chem. Biol. Interact., 1991; 77: 107-136.
22. Dekant, W., Anders, M. W., and Monks, J., Bioactivation of halogenated xenobiotics by S-conjugate formation. In: Anders, M. W., Dekant, W., Henschler, D., Oberleithner, H., and Silbernagl, S., Eds. Renal Disposition and Nephrotoxicity of Xenobiotics. San Diego, CA: Academic Press, 1993, 187-215.
23. Birner, G., Vamvakas, S., Dekant, W., and Henschler, D., Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethylene exposure in humans: implications for the risk of trichloroethylene exposure, Environ. Health Perspect., 1993; 99: 281-284.
24. Bernauer, U., Birner, G., Dekant, W., and Henschler, D., Biotransformation of trichloroethylene: dose-dependent excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation, Arch. Toxicol., 1996; 70: 338-346.
25. Green, T., Dow, J., Ellis, M. K., Foster, J. R., and Odum, J., The role of glutathione conjugation in the development of kidney tumors in rats exposed to trichloroethylene, Chem. Biol. Interact., 1997; 105: 99-117.
26. Brüning, T., Lammert, M., Kempkes, M., Thier, R., Golka, K., and Bolt, H. M., Influence of polymorphisms of GSTM1 and GSTT1 for risk renal cell cancer in workers with a long-term and high occupational exposure to trichloroethylene, Arch. Toxicol. 1997; 71: 596-599.
27. Green, T., Trichloroethylene induced in cancer in animals and its relevance to humans, J. Occup. Health, 1997; 39: 261-273.
28. Green, T., Mainwaring, G. W., and Foster, J. R., Trichloroethylene induced mouse lung tumors: studies of the mode of action and comparisons between species, Fund. Appl. Toxicol., 1997; 37: 125-130.
29. Davis, J. W., Blakeman, D. P., Jolly, R. A., Packwood, W. P., Kolaja, G. J., and Petry, T. W., S-(1,2-Dichlorovinyl)-L-cysteine-induced nephrotoxicity in the New Zealand white rabbit: characterization of proteinuria and examination of the potential role of oxidative injury, Toxicol. Pathol., 1995; 23: 487-497.
30. Zhan, Y., Cleveland, J. L., and Stevens, J. L., A role for c-myc in chemically induced cell death, Mol. Cell. Biol., 1997; 17: 6755-6764.
31. Lash, L. H., Qian, W., Putt, D. A., Jacobs, K., Elfarra, A. A., Krause, R. J., and Parker, J. C., Glutathione conjugation of trichloroethylene in rats and mice: sex-species-, and tissue-dependent differences, Drug Metab. Dispos., 1998; 26: 12-19.
32. Brüning, T., Vamvakas, S., Makropoulos, V., and Birner, G., Acute intoxication with trichloroethylene: clinical symptoms, toxicokinetics, metabolism and development of biochemical parameters for renal damage, Toxicol. Sci., 1998; 41: 157-165.
33. Lash, L. H., Putt, D. A., Brashear, W. T., Abbas, R., Parker, J. C., and Fisher, J. W., Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene, J. Toxicol. Environ. Health, 1999; 56A: 1-21.
34. Dosemeci, M., Cocco, P., and Chow, W. H., Gender differences in risk of renal cell carcinoma and occupational exposures to chlorinated aliphatic hydrocarbons, Am. J. Ind. Med., 1999; 36: 54-59.
35. Wilmer, J. W., Green, T., Dow, J., Foster, J. R., and Hext, P. M., Formic acid excretion in rats dosed with trichloroethylene: a possible explanation for long term kidney damage, Toxicol. Sci., 1998; 42: 288 (abstr. no. 1385).
36. Green, T., Dow, J., Foster, J. R., and Hext, P. M., Formic acid excretion in rats exposed to trichloroethylene: a possible explanation for renal toxicity in long-term studies, Toxicology, 1998; 127: 39-47.
37. Filser, J. G. and Bolt, H. M., Characteristics of haloethylene-induced acetonemia in rats. Arch. Toxicol., 1980; 45: 109-116.
38. 2 compounds, Arch. Toxicol., 1982; 49: 107-116.
39. Simon, P., Bolt, H. M., Filser, J. G., and Bolt, H. M., Covalent interaction of reactive metabolites with cytosolic coenzyme A as mechanism of haloethylene-induced acetonemia, Biochem. Pharmacol., 1985; 34: 1981-1986.
40. Hallier, E., Filser, J. G., and Bolt, H. M., Inhalation pharmacokinetics based on gas uptake studies. II. Pharmacokinetics of acetone in rats, Arch. Toxicol., 1981; 47: 293-304.
41. Nakagawa, Y., Kitahori, Y., Cho, M., Konishi, N., Tsumatani, K. C., Ozono, S., Okajima, E., Hirao, Y., and Hiasa, Y., Effect of hexachloro-1,3-butadiene on renal carcinogenesis in male rats pretreated with N-ethyl-N-hydroxyethyl-nitrosamine, Toxicol. Pathol., 1998; 26: 361-366.
42. Weiss, N. L., Cancer in relation to occupational exposure to trichloroethylene, Occup. Environ. Med., 1996; 53: 1-5.
43. Spirtas, R., Stewart, P. A., Lee, J. S., Marano, D. E., Forbes, C. D., Grauman, D. J., Pettigrew, H. M., Blair, A., Hoover, R. N., and Cohen, J. L., Retrospective cohort mortality study on workers exposed to trichloroethylene, Br. J. Ind. Med., 1991; 48: 515-530.
44. Axelson, O., Seldén, A., Andersson, K., and Hogstedt, C., Updated and expanded Swedish cohort study on trichloroethylene and cancer risk, J. Occup. Med., 1994; 36: 556-562.
45. Anttila, A., Pukkala, E., Sallmén, M., Hernberg, S., and Hemminki, K., Cancer incidence among Finnish workers exposed to halogenated hydrocarbons, J. Occup. Environ. Med., 1995; 37: 797-806.
46. Wong, O. and Morgan, R., Final report: Historical prospective mortality study of Hughes Aircraft employees at Air Force Plant, no 44. Alameda, CA: ENSR Health Sciences, 1990.
47. Morgan, R., Kelsh, M., Zhao, K., and Heringer S., Mortality of aerospace exposed to trichloroethylene, Epidemiology, 1998; 9: 424-431.
48. Lynge, E., Anttila, A., and Hemminki, K., Organic solvents and cancer, Cancer Causes Control, 1997; 8: 406-419.
49. Henschler, D., Vamvakas, S., Lammert, M., Dekant, W., Kraus, B., Thomas, B., and Ulm, K., Increased incidence of renal cell tumors in a cohort of cardbord workers exposed to trichloroethylene, Arch. Toxicol., 1995; 69: 291-299.
50. Kaneko, T., Wang, P. Y., and Sato, A., Assessment of health effects of trichloroethylene, Ind. Health, 1997; 35: 301-324.
51. McLaughlin, J. K. and Blot, W. J., A critical review of epidemiology studies of trichloroethylene and perchloroethylene and risk of renal-cell cancer, Int. Arch. Occup. Environ. Health, 1997; 70: 222-231.
52. Vamvakas, S., Brüning, T., Thomasson, B., Lammert, M., Baumüller, A., Bolt, H. M., Dekant, W., Birner, G., Henschler, D., and Ulm, K., Renal cell cancer correlated with occupational exposure to trichloroethylene, J. Cancer Res. Clin. Oncol., 1998; 124: 374-382.
53. Mandel, J. S., McLaughlin, J. K., Schlehofer, B., Mellemgaard, A., Helmert, U., Lindblad, P., McCrethe, M., and Adam, H. O., International renal cell cancer study. IV. Occupation, Int. J. Cancer, 1995; 61: 601-605.
54. Blair, A., Hartge, P., Stewart, P.A., McAdams, M., and Lubin, J., Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: an extended follow up, Occup. Environ. Med., 1998; 55: 161-171.
55. Greiser, E. and Molzahn, M., Multizentrische Nierenund Urothel-Carcinom-Studie (Abschlußbericht), (Schriftenreihe der Bundesanstalt für Arbeitsschutz, Forschung Fb 780), Bremerhaven: Wissenschaftsverlag, 1997.
56. Pesch, B., Haerting, J., Klimpel, A., Oelschlägel, B., Ranft, U., and Schill, W., Occupational risk factors for urothelial carcinoma: agent-specific results from a case-control study in Germany, Int. J. Epidemiol., 1999; in press.
57. Pesch, B., Haerting, J., and Ranft, R., Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany, submitted.
58. Brüning, T., Golka, K., Makropoulos, V., and Bolt, H. M., Preexistence of chronic tubular damage in cases of renal cell cancer after long and high exposure to trichloroethylene, Arch. Toxicol., 1996; 70: 259-260.
59. Bazzi, C., Petrini, C., Rizza, V., Arrigo, G., Beltrame, A., and D'Amico, G., Characterization of proteinuria in primary glomerulonephritides. SDS-PAGE patterns: clinical significance and prognostic value of low-molecular-weight ("tubular") proteins. Am. J. Kidney Dis., 1997; 29: 27-35.
60. Brüning, T., Mann, H., Melzer, H., Sundberg, A. G. M., and Bolt, H. M., Pathological excretion patterns of urinary proteins in renal cell cancer patients exposed to trichloroethylene, Occup. Med., 1999; 49: 1-7.
61. Golka, K., Hartert-Raulf, T., Schöps, W., Kierfeld, G., Brüning, T., and Bolt, H. M., Subclinical changes in urinary protein excretion of renal cell cancer patients: Effect of high occupational exposure to trichloroethylene, Centr. Eur. J. Occup. Environ. Med., 1997; 3: 167-174.
62. Brüning, T., Sundberg, A. G. M., Birner, G., Lammert, M., Bolt, H. M., Appelkvist, E. E., Nilsson, R., and Dallner, G., Glutathione transferase alpha as a marker for tubular damage after trichloroethylene exposure, Arch. Toxicol., 1999; 73: 246-254.
63. Sherratt, P. J., Manson, M. M., Green, T., and Hayes, J. D., Increased activation of dihaloalkanes in rat liver by upregulation of class theta glutathione-S-transferase T1, Toxicol. Sci., 1998; 42: 1-S, 275 (abstract no. 1350).
64. Thier, R., Wiebel, F. A., Schulz, T. G., Kinkel, A., Brüning, T., and Bolt, H. M., Comparison of GST theta activity in liver and kidney of four species, Arch. Toxicol., 1997; Suppl. 20: 471-474.
65. 35S-glutathione, Arch. Toxicol., 1998; 72: 811-815.
66. Amet, Y., Berthon, F., Fournier, G., Dréano, Y., Bardou, L., Clédes, J., and Ménez, J. F., Cytochrome P 450 4A and 2E1 expression in human kidney microsomes, Biochem. Pharmacol., 1997; 53: 765-771.
67. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F. M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhou, F., Li, H., Wei, M. H., Chen, F., Glenn, G., Choyke, P., Walther, M. M., Weng, Y., Duan, D. S. R., Dean, M., Glavac, D., Richards, F. M., Crossey, P. A., Ferguson-Smith, M. A., Le Paslier, D., Chumakov, I., Cohen, D., Chinault, A. C., Maher, E. R., Linehan, W. M., Zbar, B., and Lerman, M. I., Identification of the von Hippel-Lindau disease tumor suppressor gene, Science, 1993; 260: 1317-1320.
68. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wie, M. W., Li, H., Latif, F., Liu, S., Chen, F., Duh, F. M., Lubensky, I., Duan, D. R., Florence, C., Pozzati, R., Walther, M. M., Bander, N. H., Grossman, H. B., Brauch, H., Pomer, S., Brooks, J. D., Isaacs, W. B., Lerman, M. I., Zbar, B., and Linehan, W. M., Mutations of the VHL tumor suppressor gene in renal carcinoma, Nature Genet., 1994; 7: 85-89.
69. Brüning, T., Weirich, G., Hornauer, M. A., Höfler, H., and Brauch, H., Renal cell carcinoma in trichloroethylene (TRI)-exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumor suppressor gene, Arch. Toxicol., 1997; 71: 332-335.
70. Brauch, H., Weirich, G., Hornauer, M.A., Störkel, S., Wöhl, T., and Brüning, T., Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma, J. Natl. Cancer Inst., 1999; 91: 854-861.
71. Foster, K., Prowse, A., van den Bergh, F. S., Hulsbeek, M. M. F., Crossey, P. A., Richards, F. M., Cairns, P., Affara, N. A., Ferguson-Smith, M. A., Buys, C. H. C. M., and Maher, E. R., Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in non-familial clear cell renal carcinoma, Hum. Mol. Genet., 1994; 3: 2169-2173.
72. Shuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., Zbar, B., Lerman, M. I., and Yao, M., Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinoma, Cancer Res,. 1994; 54: 2852-2855.
73. Whaley, J. M., Naglich, J., Gelbert, L., Hsia, Y. E., Lamiell, J. M., Green, J. S., Collins, D., Neumann, H. P. H., Laidlaw, J., Li, F. P., Klein-Szanto, A. J. P., Seizinger, B., and Kley, N., Germline mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am. J. Hum. Genet., 1994; 55: 1092-1102.
74. Kenck, C., Wilhelm, M., Bugert, P., Staehler, G., and Kovacs, G., Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas, J. Pathol. 1996; 179: 157-161.
75. Brauch, H., Weirich, G., Brieger, J., Glava, D., Rödl, H., Eichinger, M., Feurer, M., Weidt, E., Puranakanitsthan, Ch., Neuhaus, Chr., Pomer, S., Brenner, W., Schirmacher, P., Störkel, St., Rotter, M., Maera, A., Gugeler, N., and Decker, H. J., VHL alterations in human cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation, submitted.
76. Henschler, D., Eder, E., Neudecker, T., and Metzler, M., Carcinogenicity of trichloroethylene: fact or artifact?, Arch. Toxicol., 1977; 37: 233-236.
77. Weisburger, E. K., Carcinogenicity studies on halogenated hydrocarbons, Environ. Health Perspect., 1977; 21: 7-16.
78. Berlin, A., Draper, M., Krug, E., Roi, R., and van der Venne, M. T., Eds. The Toxicology of chemicals I: Carcinogenicity, Vol. II: Summary Reviews of the Scientific Evidence, (chap. Trichloroethylene). Luxembourg: Office for Official Publications of the European Communities, 1990; 111-119.
79. Ohh, M. and Kaelin W. G., Jr., The von Hippel-Lindau tumor protein: new perspectives, Mol. Med. Today, 1999; 5: 257-263.
80. Stebbins, C .E., Kaelin, W. G., Jr., and Pavletich, N. P., Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function, Science, 1999; 284: 455-461.
81. Kinzler, K. W. and Vogelstein, B., Lessons from hereditary colorectal cancer, Cell, 1996; 87: 159-170.
82. Zbar, B., Kishida, T., Chen, F., Schmidt, L., Maher, E., Richards, F. M., Crossey, P. A., Webster, A. R., Affara, N. A., Ferguson-Smith, M. A., Brauch, H., Glavac, D., Neumann, H. P. H., Tisherman, S., Mulvehill, J., Gross, D., Shuin, T., Whaley, J., Seizinger, B., Kley, N., Olschwang, S., Boisson, C., Richard, S., Lips, C. H. M., Linehan, M., and Lerman, M. I., Germline mutations in the von Hippel-Lindau disease gene (VHL) in families from North America, Europe and Japan, Hum. Mutat., 1996; 8: 348-357.
83. Brauch, H., Kishida, T., Glavac, D., Chen, F., Pausch, F., Höfler, H., Latif, F., Lerman, M. I., Zbar B., and Neumann, H. P. H., non-Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region in Germany: evidence for a founder effect, Hum. Genet., 1995; 95: 551-556.
84. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S. R., Gnarra, J. R., Linehan, W. M., and Beylin, S., Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma, Proc. Natl. Acad. Sci. U.S.A., 1994; 91: 9700-9704.
85. Knudson, A., Mutation and cancer: statistical study of retinoblastoma, Proc. Natl. Acad. Sci. U.S.A., 1971; 68: 820-823.
86. Kanjilal, S., Strom, S. S., Clayman, G. L., Weber, R. S., El-Naggar, A. K., Kapur, V., Cummings, K. K., Hill, L. A., Spitz, M .R., Kripke, M. L., and Ananthaswamy, H. N., P53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field characterization, Cancer Res., 1995; 55: 3604-3609.
87. Yang, K., Lindblad, P., Egevad, L., and Hemminki, K., Novel somatic mutations in the VHL gene in Swedish archived sporadic renal cell carcinoma, Cancer Lett., 1999; 141: 1-8.
88. Dekant, W., Vamvakas, S., Berthold, K., Schmidt, S., Wild, D., and Henschler, D., Bacterial beta-lyase mediated cleavage and mutagenicity of cysteine conjugates derived from the nephrocarcinogenic alkenes trichloroethylene, tetrachloroethylene and hexachlorobutadiene, Chem. Biol. Interact., 1986; 15: 31-45.
89. Vamvakas, S., Dekant, W., Berthold, K., Schmidt, S., Wild, D., and Henschler, D., Enzymatic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates, Biochem. Pharmacol., 1987; 36: 2741-2748.
90. Commandeur, J. N. M., Boogaard, J., Mulder, G. J., and Vermeulen, N. P. E., Mutagenicity and cytotoxicity of two regioisomeric mercapturic acids and cysteine S-conjugates of trichloroethylene, Arch. Toxicol., 1991; 65: 373-380.
91. Richter, H. and Vamvakas, S., S-(1,2-dichlorovinyl)-L cysteine-induced dedifferentiation and p53 gene mutations in LLC-PK1 cell: a comparative investigations with S-(2-chloroethyl)cysteine, potassium bromate, cisplatinum and styrene oxide, Toxicol. Lett., 1998; 94: 145-157.
92. Dekant, W., Vamvakas, S., and Anders, M. W., Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate ß-lyase, Drug Metab. Rev., 1989; 20: 43-83.
93. Shiao, Y-H., Rice, J. M., Anderson, L. M., Diwan, B. A., and Hard, G. C., Von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors, J. Natl. Cancer Inst,. 1998; 22: 1720-1723.
94. Simon, T. W., Combining physiologically based pharmacokinetic modelling with Monte Carlo simulation to derive an acute inhalation guidance value for trichloroethylene, Regul. Toxicol. Pharmacol., 1997; 26: 257-270.
95. Neumann, H. G., Vamvakas, S., Thielmann, H. W., Gelbke, H. P., Filser, J. G., Reuter, U., Greim, H., Kappus, H., Norpoth, K. H., Wardenbach, P., and Wichmann, H. E., Changes in the classification of carcinogenic chemicals in the work area. Section III of the German List of MAK and BAT values, Int. Arch. Occup. Environ. Hlth., 1998; 71: 566-574.
96. Roldán-Arjona, T., Garciá-Pedrajas, M. D., Luque-Romero, F. L., Hera, C., and Pueyo, C., An association between mutagenicity of the Ara test of Salmonella typhimurium and carcinogenicity in rodent for 16 halogenated aliphatic hydrocarbons, Mutagenesis, 1991; 6: 199-205.
97. Simmon, V. F., Kauhanen, K., and Tardiff, R. G., Mutagenic activity of chemicals identified in drinking water: In: Scott, D., Bridges, B. A., and Soberls, F. H., Eds. Progress in Toxicology, Amsterdam: Elsevier/ North-Holland, 1977; 249-258.
98. Baden, J. M., Kelley, M., Mazze, R. I., and Simmon, V. F., Mutagenicity of inhalation anaesthetics: trichloroethylene, divinyl ether, nitrous oxide and cyclopropana, Br. J. Anaesthesiol., 1979; 51: 417-421.
99. Bartsch, H., Malaveille, C., Barbin, A., and Planche, G., Mutagenic and alkylating metabolites of halo-ethylenes, chlorobutadienes and dichlorobutenes produced by rodent or human liver tissues, Arch. Toxicol., 1979; 41: 249-277.
100. Crebelli, R., Bignami, M., Conti, L., and Carere, A., Mutagenicity of trichlororethylene in Salmonella typhimurium TA100, Ann. Ist. Super. Sanitá, 1982; 18: 117-122.
101. Shimada, T., Swanson, A. F., Leber, P., and Williams, G. M., Activities of chlorinated ethane and ethylene compounds in the Salmonella/rat microsome mutagenesis and rat hepatocyte/DNA repair assays under vapor phase exposure conditions, Cell. Biol. Toxicol., 1985; 1: 159-179.
102. Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B., and Zeiger, E., Salmonella mutagenicity tests II. Results from the testing of 270 chemicals, Environ. Mutagen., 1986; 8: (Suppl. 7), 1-119.
103. McGregor, D. B., Reynolds, D. M., and Zeiger, E., Conditions affecting the mutagenicity of trichloroethylene in Salmonella, Environ. Mol. Mutagen., 1989; 13: 197-202.
104. Kringstad, K. P., Ljungquist, P. O., de Sousa, F., and Strömberg, L. M., Identification and mutagenic properties of some chlorinated aliphatic compounds in the spent liquor from kraft pulp chlorination, Environ. Sci. Technol., 1981; 15: 562-566.
105. Bronzetti, G., Zeiger, E., and Frezza, D., Genetic activity of trichloroethylene in yeast, J. Environ. Pathol. Toxicol., 1978; 1: 411-418.
106. Crebelli, R., Conti, G., Conti, L., and Carere A., Mutagenicity of trichloroethylene, trichloroethanal and chloral hydrate in Aspergillus nidulans, Mutat. Res., 1985; 155: 105-111.
107. Rossi, A. M., Migliore, L., Barale, R., and Loprieno, N., In vivo and in vitro mutagenicity studies of a possible carcinogen, trichloroethylene and its two stabilizers, epichlorohydrin and 1,2-epoxybutane, Teratog. Carcinog. Mutagen., 1983; 3: 75-87.
108. Caspary, W. J., Langenbach, R., Penman, B. W., Crespi, C., Myhr, B. C., and Michell, A. D., The mutagenic activity of selected compounds at the TK locus: rodent vs. human cells, Mutat. Res. 1988; 196: 61-81.
109. Galloway, S. M., Armstrong, M. J., Reuben, C., Colman, S., Brown, B., Cannon, C., Bloom, A. D., Nakamura, F., Ahmed, M., Duk, S., Rimpo, J., Margolin, B. H., Resnick, M. A., Anderson, B., and Zeiger, E., Chromosome aberration and sister chromatid exchanges in Chinese hamster ovary cells: evaluation of 108 chemicals, Environ. Mol. Mutagen., 1987; 10: 1-175.
110. Price, P. J., Hassett, C. M., and Mansfield, J. L. Transforming activities of trichlororethylene and proposed industrial alternatives, In Vitro, 1978; 14: 290-293.
111. 2 and interaction of a metabolic with liver DNA in rats and mice, J. Toxicol. Environ. Health, 1982; 9: 797-813.
112. Walles, S. A. S., Induction of single-strand breaks in DNA of mice by trichloroethylene and tetrachloroethylene, Toxicol. Lett. 1986; 31: 31-35.
113. Nelson, M. A. and Bull, R. J., Induction of strand breaks in DNA by trichloroethylene and metabolites in rat and mouse liver in vivo, Toxicol., Appl. Pharmacol., 1988; 94: 45-54.
114. Fahrig, R., The mammalian spot test (Fallfleckentest) with mice, Arch. Toxicol. 1977; 38: 87-98.
115. Doolittle, D. J., Müller, G., and Scribner, H. E., The in vivo - in vitro hepatocyte assay for assessing DNA repair and DNA replication: studies in the CD-1 mouse. Food Chem. Toxicol., 1987; 25: 399-405.
116. Duprat, P. and Gradinski, D., Cytogenectic effect of trichloroethylene in the mouse as evaluated by the micronucleus test. IRCS Med. Sci., 1980; 8: 182.
117. Garabrant, D. H., Held, J., Langholz, B., and Bernstein, L., Mortality of aircraft manufacturing workers in Southern California, Am. J. Ind. Med., 1988; 13: 683-693.
118. Shelby, M. D., Erexson, G. L., Hook, G. J., and Tice, R. R., Evaluation of a three-exposure mouse bone marrow micronucleus protocol. Results with 49 chemicals, Environ. Mol. Mutagen., 1993; 21: 160-179.
119. Allen, J. W., Collins, B. W., and Evansky, P. A., Spermatid micronucleus analyses of trichloroethylene and chloral hydrate effects in mice, Mutat. Res., 1994; 323: 81-88.
120. Kligerman, A. D., Bryant, M. F., Doerr, C. L., Erexson, G. L., Evansky, P. A., Kwanyuen, P., and McGee, J. K., Inhalation studies of the genotoxicity of trichloroethylene to rodents, Mutat. Res., 1994; 322: 87-96.
121. Slacik-Erben, R., Roll, R., Franke, G., and Uehleke, H., Trichloroethylene vapours do not produce dominant lethal mutations in male mice, Arch.Toxicol., 1980; 45: 37-44.
122. Henschler, D., Romen, W., Elsässer H. M., Reichert, D., Eder, E., and Radwan, Z., Carcinogenicity study of trichloroethylene by long-term inhalation in three animal species, Arch. Toxicol., 1980; 43: 237-248.
123. Fukuda, K., Takemoto, K., and Tsurata, H., Inhalation carcinogenicity of trichloroethylene in mice and rats, Ind. Health, 1983; 21: 243-254.
124. Maltoni, C., Lefemine, G., Cotti G., and Perino, G., Long-term carcinogenicity bioassays on trichloroethylene administered by inhalation to Sprague-Dawley rats and Swiss and B6C3F1 mice, Ann. N.Y. Acad. Sci., 1988; 534: 316-342.
125. NCI, National Cancer Institute, Bioassay of trichloroethylene for possible carcinogenicity. NCI Technical Report, No. 2. Bethesda, MD: US Dept. of Health, Education, and Welfare, 1976.
126. Henschler, D., Elsässer, H., Romen, W., and Eder, E., Carcinogenicity study of trichloroethylene, with and without epoxide stabilizers, in mice, J. Cancer Res. Clin. Oncol., 1984; 107: 149-156.
127. NTP, National Toxicology Program. Toxicology and carcinogenesis studies of trichloroethylene in four strains of rats (ACI, August, Marshall, Osborne-Mendel) (gavage studies). National Toxicology Program TR-273, 1988.
128. NTP, National Toxicology Program. Carcinogenesis studies of trichloroethylene (without epichlorhydrin) in F344/N rats and B6C3F1 mice (gavage studies). National Toxicology Program TR-243, 1990.
129. Duuren, B. L., Goldschmidt, B. M., Loenwengart, G., Smith, A. C., Melchionne, S., Seidman, I., and Roth, D., Carcinogenicity of halogenated and aliphatic hydrocarbons in mice, J. Natl. Cancer Inst., 1979; 63: 1433-1439.
130. Mersh-Sundermann, V., Miller, G., and Hofmeister, A., Examination of mutagenicity of organic microcontaminations of the environment. IV. Communication. Zbl. Hyg., 1989; 189: 266-271.